Open Access

[Retracted] Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and ‑9 activities

  • Authors:
    • Rui Wang
    • Junhai Wang
    • Tianfu Dong
    • Jun Shen
    • Xitao Gao
    • Jun Zhou
  • View Affiliations

  • Published online on: February 10, 2025     https://doi.org/10.3892/ol.2025.14923
  • Article Number: 177
  • Copyright : © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2025
Volume 29 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang R, Wang J, Dong T, Shen J, Gao X and Zhou J: [Retracted] Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and ‑9 activities. Oncol Lett 29: 177, 2025.
APA
Wang, R., Wang, J., Dong, T., Shen, J., Gao, X., & Zhou, J. (2025). [Retracted] Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and ‑9 activities. Oncology Letters, 29, 177. https://doi.org/10.3892/ol.2025.14923
MLA
Wang, R., Wang, J., Dong, T., Shen, J., Gao, X., Zhou, J."[Retracted] Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and ‑9 activities". Oncology Letters 29.4 (2025): 177.
Chicago
Wang, R., Wang, J., Dong, T., Shen, J., Gao, X., Zhou, J."[Retracted] Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and ‑9 activities". Oncology Letters 29, no. 4 (2025): 177. https://doi.org/10.3892/ol.2025.14923